BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 4  |  Page : 8848-8853 Full Version
Sociodemographic and immunohistochemical expression of p53 in nasopharyngeal carcinoma
Int J Biol Med Res. 2026; 17(4): 8848-8853  |  DOI: 10.65048/ijbmr.2026.17.4.8848.1100
Olorungbeja Oluwasegun Victor¹, Jonathan Madukwe², Solomon Matthias Gamde³
¹Department of Medical Laboratory Science, Bingham University, Karu, Nigeria
²DHistopathology Unit, National Hospital, Abuja, Nigeria
³Department of Medical Laboratory Science, Plateau State University, Bokkos, Nigeria
Correspondence Address :
Dr.Solomon Matthias Gamde,
Department of Medical Laboratory Science,
Plateau State University, Bokkos, Nigeria
*ORCID: https://orcid.org//0000-0002-7631-8782 E-mail: solomongamde@plasu.edu.ng
Received: June 2, 2026 Accepted: August 17, 2026 Published: October 3, 2026

Abstract
Nasopharyngeal carcinoma (NPC) is an aggressive malignant tumour of the head and neck region with a distinct geographic and ethnic distribution. Its development is often associated with genetic alterations, viral infections such as Epstein-Barr virus (EBV), and environmental factors. Among the molecular markers implicated in its pathogenesis, the tumour suppressor protein p53 plays a critical role in regulating cell cycle, DNA repair, and apoptosis. Aberrant expression of p53 has been reported in various malignancies, including NPC, and may provide important diagnostic, prognostic, and therapeutic implications. This study investigates the immunohistochemical expression of p53 in nasopharyngeal carcinoma cases diagnosed at the National Hospital, Abuja. Formalin-fixed, paraffin-embedded tissue samples of confirmed NPC were retrieved and subjected to immunohistochemical staining using monoclonal antibodies specific for p53. The expression pattern was evaluated based on nuclear staining intensity and percentage of positive tumour cells, and results were correlated with clinicopathological parameters such as age, sex, and histological subtype. Findings from this study revealed that a significant proportion of NPC cases showed overexpression of p53 protein, suggesting possible involvement of p53 pathway alterations in the tumorigenesis of NPC among Nigerian patients. The expression was more pronounced in undifferentiated carcinoma compared to differentiated subtypes, with no significant gender variation. The study concludes that p53 overexpression is common in NPC in Abuja and may serve as a useful biomarker in understanding tumour biology, prognosis, and in guiding therapeutic strategies. It further recommends larger multicenter studies incorporating molecular assays to validate the prognostic significance of p53 in NPC within the Nigerian population.
Keywords
Nasopharyngeal carcinoma, p53, immunohistochemistry, tumour suppressor gene, Abuja, Nigeria.

References

[1] Okekpa S I, Mydin R B S M N, Mangantig E, Azmi N S A, Zahari S N S, Kaur G,  Musa Y. 2019. Nasopharyngeal carcinoma (NPC) risk factors: A systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian region. 
[2] Adoga AA, Kokong DD, Ma’an ND, Silas OA, Dauda AM, Yaro JP, Mugu JG, Mgbachi CJ, Yabak CJ. The epidemiology, treatment, and determinants of outcome of primary head and neck cancers at the Jos University Teaching Hospital. South Asian Journal of Cancer.2018; 7(3): 183-187. 
[3] Sun L, Wang Y, Shi J, Zhu W, Wang X. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma. Pathology & Oncology Research. 2020;26(3):1893–1901.
[4] Batsakis J G, Solomon A R,  Rice D H. The pathology of head and neck tumors: Carcinoma of the nasopharynx, Part 11. Head & Neck Surgery. 2012; 3(6): 511–524. https://doi.org/10.1002/hed.2890030610
[5] Chua M L K, Sham J S T,  Wei W I. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence. BMC Cancer. 2013; 12: 98. https://doi.org/10.1186/1471-2407-12-98
[6] Her C. Nasopharyngeal cancer in Southeast Asian patients. American Family Physician. 2001; 63(9): 1776–1782.
[7] Dandekar V V, Thotakura N I,  Alam H B. Nasopharyngeal carcinoma. StatPearls Publishing. 20241. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK558922/
[8] Levine A J. Million years of evolution and 40 years of discovery. Nature Reviews Cancer. 2020; 20(8): 471–480. https://doi.org/10.1038/s41568-020-0262-1
[9] Zhang Y, Rumgay H, Li M, Cao S, Chen W. Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health and Surveillance. 2023;9: e49968.
[10] Gamde SM, Francis L, Adisa JO. Immunohistochemistry in Cancer Diagnosis: A Review. Perspectives in Medical Research. 2024;12(2): 15-21.DOI: 10.47799/pimr.1202.03.


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications